Volume-targeted ventilation.

Martin Keszler

doi:10.1016/j.earlhumdev.2006.09.008

Home/Archive/PubMed

PubMed · 17069993

Volume-targeted ventilation.

Martin Keszler

View original source ↗Export metadata ↓

Abstract

Recognition that volume, not pressure, is the key factor in ventilator-induced lung injury and the association of hypocarbia and brain injury dictate the need to better control delivered tidal volume. Volume-controlled ventilation, though much improved, still suffers from loss of volume due to endotracheal tube leak and gas compression in the circuit. Recent microprocessor-based modifications of pressure-limited, time-cycled ventilators combine advantages of pressure-limited ventilation with the ability to deliver a more consistent tidal volume. Each of the modes has advantages and disadvantages, with limited data available to judge their effectiveness. The Volume Guarantee mode, studied most thoroughly, provides automatic weaning of peak pressure in response to improving lung compliance and respiratory effort. More consistent tidal volume, fewer excessively large breaths, lower peak pressure, less hypocarbia and lower levels of inflammatory cytokines have been documented. It remains to be seen if these short-term benefits translate into shorter duration of ventilation or reduced incidence of chronic lung disease.

Explore related subjects

Humans Infant, Newborn Infant, Premature Pulmonary Ventilation Respiration, Artificial Tidal Volume Ventilators, Mechanical Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Martin Keszler. 2006-10-27. Volume-targeted ventilation.. https://doi.org/10.1016/j.earlhumdev.2006.09.008

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗